We saw another big move in IGC, India Globalization Capital, in trading today. The stock traded as high as $7.48 before retreating to under $6 per share in the latter part of the session. This stock signaled a long entry for us a few days ago at $3.25, and I expected to be in the […]
Read Article
The stock TTOO, T2 Biosystems Inc., was bullish in trading today. The stock was up over 6% towards the end of the session, primary due to news from Wednesday that the company’s diagnostic device for identifying borrelia infections for patients suspected of having early Lyme disease was indicated to be more accurate than other existing […]
Read Article
There were big moves and subsequent pullbacks today for many biotech and healthcare stocks. Continuing the recent theme of inconsistent trading, most symbols struggled to maintain momentum throughout the session. AMRN, for example, was up very sharply at the open, moving up from around $12.00 to a high of $14.64, and then proceeding to give […]
Read Article
We saw some strong moves up and down in the biotech/healthcare space today. One example is Fibrocell Science Inc. The stock was up over 10% towards the middle of the session due to rumors of an FDA contract. However, this has yet to be confirmed. Meanwhile, Spectrum Pharmaceuticals was down nearly 20% after releasing updated […]
Read Article
We saw some major moves in biotech/healthcare today. India Globalization Inc. (IGC) was up over 70% at its peak today, trading above $4 after opening just above $2.50 per share. While there is no pressing news behind the move, the sector has been fairly hot lately and IGC appears to be in a good position […]
Read Article
Shares of Altimmune Inc. (ALT) rose very sharply in trading over the last 24 hours. On the surface, it was alleged that the company’s shares rose due to positive news from its pipeline developments for its phase 1 and 2 research. However, the company recently completed a 1:30 reverse split, meaning that every 30 shares […]
Read Article
We had big movements in two stocks in the biotech/healthcare space. One was Abbvie (ABBV), whose stock was hammered late in the trading session after it was announced that the California Department. Of Insurance is suing the company over alleged kickbacks in the promotion of Humira. Meanwhile, Viking Therapeutics (VKTX) was up dramatically on successfully […]
Read Article
Opko Health Inc. rose sharply today in trading as the recoup nearly 50% of its losses from September 7th. The stock (Ticker: OPK) slumped sharply this month due to the news that the SEC is investigating an alleged stock price manipulation scheme that affected OPK in addition to other stocks. Numerous class action lawsuits have […]
Read Article
Opko Health Inc. was hammered when trading resumed today. The stock was down over 10% when trading resumed today after being halted on September 7th. The reason for the drop is a class action lawsuit against the company on the heels of an SEC complaint of stock price manipulation in the stock. Here’s a recap […]
Read Article
Today’s trading in biotech and healthcare was rough, once again. However, we did get some long signals for a couple stocks, EVH and FCSC. The later was actually triggered late yesterday but was still active today. Overall, upside potential seems strongest for generic healthcare stocks, but biotech has begun to catch up. Here’s what happened.
Read Article
